FLEXAFEN Trademark

Trademark Overview

On Monday, November 14, 2022, a trademark application was filed for FLEXAFEN with the United States Patent and Trademark Office. The USPTO has given the FLEXAFEN trademark a serial number of 97676965. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Sunday, November 17, 2024. This trademark is owned by Truegenics Pte. Ltd.. The FLEXAFEN trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements for joint pain

General Information

Serial Number97676965
Word MarkFLEXAFEN
Filing DateMonday, November 14, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSunday, November 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements

Goods and ServicesNutritional supplements for joint pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 17, 2022
Primary Code005
First Use Anywhere DateThursday, March 2, 2023
First Use In Commerce DateThursday, March 2, 2023

Trademark Owner History

Party NameTruegenics Pte. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type78 - NOT AVAILABLE
AddressSingapore 188979
SG
Party NameTruegenics Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type78 - NOT AVAILABLE
AddressSingapore 188979
SG

Trademark Events

Event DateEvent Description
Wednesday, August 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 17, 2022NEW APPLICATION ENTERED
Thursday, November 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 26, 2023ASSIGNED TO EXAMINER
Wednesday, August 30, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 30, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, August 30, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, August 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, August 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2024SOU EXTENSION 1 FILED
Thursday, August 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 23, 2024USE AMENDMENT FILED
Friday, August 23, 2024PETITION TO REVIVE-GRANTED
Friday, August 23, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, August 23, 2024NOTICE OF REVIVAL - E-MAILED
Friday, August 23, 2024TEAS STATEMENT OF USE RECEIVED
Friday, August 23, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Sunday, October 27, 2024SOU EXTENSION 1 GRANTED
Sunday, October 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Sunday, October 27, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, November 17, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, November 17, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

flexafen pain joint supplements nutritional